Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability
Source abstract
Abstract
With the purpose of improving the water solubility and oral bioavailability, ursolic acid nanoparticles (UANs) were prepared by the emulsion solvent evaporation method, and the nanosuspension was freeze-dried into powder. The optimal conditions for preparing nanoparticles were screened out using single-factor experiment. Take advantage of the optimal conditions, UA nanoemulsion had mean particle size (MPS) of 69.7 ± 15.6 nm and polydispersity index value (PI) of 0.005. The MPS of UA nanosuspension was gained at 100.2 ± 12.1 nm (PI = 0.005), after the organic solvent was removed by rotary evaporator. Finally, UANs possessing an MPS of 157.5 ± 28.0 nm (PI = 0.005) and zeta potential of 20.33 ± 1.67 mV were obtained after freeze-dried. UANs were investigated using SEM, XRD, DSC, TGA and further explored their equilibrium solubility, dissolution rate, solvent residue analysis, cellular antioxidant activity and oral bioavailability. All the results above showed that UA in UANs was in the amorphous state. The result of solubility test figured that the equilibrium solubility of UANs was 13.48 times in simulated gastric fluid (SGF), 11.79 times in simulated intestinal fluid (SIF) and 23.99 times in deionized water than raw UA. Accordingly, the dissolution rate of UANs in SGF and SIF had an apparent enhancement. The oral bioavailability of UANs increased 2.68 times than raw UA. UANs improved antioxidant activity toward cells compared with raw UA, and EC50 of UANs reduced 37.5 times than raw UA. The residual contents of trichloromethane and ethanol were separated up to the mustard of the ICH limit for class III and class II solvents. The results above indicated that UANs possesses a value of application on enhancement oral bioavailability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Natural product bioactivities and synthesis · Biological Activity of Diterpenoids and Biflavonoids · Essential Oils and Antimicrobial Activity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Forest Plant Ecology, Ministry of Education, Northeast Forestry University
Funding
National Natural Science Foundation of China · Central Universities
References (40)
Show source-provided references
1. 10.1016/j.bcp.2013.03.00610.1016/j.bcp.2013.03.006 ↗
2. 10.1111/j.1755-5949.2012.00369.x10.1111/j.1755-5949.2012.00369.x ↗
3. Li WG, Zhao XH, Sun XL, et al. Evaluation of antioxidant ability in vitro and bioavailability of trans-cinnamic acid nanoparticle by liquid antisolvent precipitate. J Nanomater. 2016;2016:9518362.
4. 10.1007/s11051-016-3339-810.1007/s11051-016-3339-8 ↗
5. 10.1016/j.canlet.2012.02.03710.1016/j.canlet.2012.02.037 ↗
6. Xiong B, Lei ZY, Chen H. Research progress of ursolic acid pharmacology. Foreign Med Sci Sect Pharmacy. 2004;31:133–136.
7. 10.1016/j.ejps.2015.01.00710.1016/j.ejps.2015.01.007 ↗
8. Qiu L, Zhao XH, Zu YG, et al. Preparation, characterization, and dissolution characteristics of ursolic acid nanoparticles prepared by emulsion solvent evaporation method. Chin Tradit Herbal Drugs. 2018;49:2387–2393.
9. Ou XX, Wang ZM, Feng L. Preparation and bioavailability of ursolic acid self-microemulsion. Chin J ETMF. 2012;18:36–39.
10. Qi N, Liu G, Liao Y, et al. Preparation and in vivo release behavior investigation of ursolic acid liposome. Chin J ETMF. 2013;19:28–31.
11. 10.1590/S1984-8250201500010001110.1590/S1984-82502015000100011 ↗
12. Zong W, Zhang H, Yuan WL, et al. Study on the preparation of ursolic acid-β-cyclodextrin inclusion complex by ultrasonic wave and its characteristic. China Acad J Electronic. 2011;32:237–239.
13. 10.1080/10408398.2014.97135310.1080/10408398.2014.971353 ↗
14. 10.1016/j.ijpharm.2007.09.02910.1016/j.ijpharm.2007.09.029 ↗
15. 10.1007/s11051-008-9357-410.1007/s11051-008-9357-4 ↗
16. 10.1016/j.foodchem.2011.10.08310.1016/j.foodchem.2011.10.083 ↗
17. 10.2174/156720181366616030714275710.2174/1567201813666160307142757 ↗
18. Huang H, Zhang BF. Determination of ursolic acid and oleanolic acid in different varieties of kuding tea. China Acad J Electronic Publishing House. 2012;40:243–245.
19. 10.1039/C6RA12896C10.1039/C6RA12896C ↗
20. 10.1016/j.ijpharm.2010.10.05510.1016/j.ijpharm.2010.10.055 ↗
21. 10.1016/j.ijpharm.2015.03.07110.1016/j.ijpharm.2015.03.071 ↗
22. 10.1016/j.ijpharm.2012.11.03310.1016/j.ijpharm.2012.11.033 ↗
23. 10.3109/10717544.2014.88143810.3109/10717544.2014.881438 ↗
24. 10.1021/jf801381y10.1021/jf801381y ↗
25. 10.1021/jf071516610.1021/jf0715166 ↗
26. 10.1016/j.ijpharm.2014.12.00310.1016/j.ijpharm.2014.12.003 ↗
27. 10.1016/j.bbamem.2007.01.01210.1016/j.bbamem.2007.01.012 ↗
28. Raymond CR, Paul JS, Marian EQ. Handbook of pharmaceutical excipients. 6th ed. Pharmaceutical Press; 2009.
29. 10.2147/IJN.S4049310.2147/IJN.S40493 ↗
30. 10.1016/j.ejps.2013.12.00510.1016/j.ejps.2013.12.005 ↗
31. Zu YG, Yu XY, Zhao XH, et al. Nanocrystallization of the pharmaceutically active agent Genipin by an emulsion solvent evaporation method. Int J Nanomed. 2014;2014:1–13.
32. Zhang Y, Li Y, Zhao XH, et al. Preparation, characterization and bioavailability of oral puerarin nanoparticles by emulsion solvent evaporation method. RSC Adv. 2016;6:889–901.
33. 10.1007/BF0297615610.1007/BF02976156 ↗
34. 10.1016/j.jddst.2015.08.00110.1016/j.jddst.2015.08.001 ↗
35. 10.1016/j.ijpharm.2009.11.00710.1016/j.ijpharm.2009.11.007 ↗
36. 10.1081/DDC-12002131010.1081/DDC-120021310 ↗
37. 10.1016/j.jfoodeng.2011.07.03410.1016/j.jfoodeng.2011.07.034 ↗
38. 10.1016/j.msec.2016.09.08010.1016/j.msec.2016.09.080 ↗
39. 10.1016/j.ijpharm.2005.05.01410.1016/j.ijpharm.2005.05.014 ↗
40. 10.1016/j.ijpharm.2013.05.06110.1016/j.ijpharm.2013.05.061 ↗